medline.ch Onkologie Urologische Tumoren

	Reply to the Letter to the Editor: Diagnostic performance of the clear cell likelihood score integrated with cystic degeneration or necrosis on MR imaging for identifying clear cell renal cell carcinoma in cT1 solid renal masses. Insights Imaging Ning X, Wang H. PMID: 42213314 [PubMed]
	Comparative efficacy and safety of open, laparoscopic, and robot-assisted radical cystectomy: a systematic review and network meta-analysis. J Robot Surg Zhao L, Chen HM, Li YT, Zhang T, Yang JW, Wang L, Li XR, Shao LC, Chen SY. PMID: 42213216 [PubMed - indexed for MEDLINE]
	Comparison of PET imaging of [18F]F-FAPI and [18F]F-FDG for diagnosis of suspected lymph node metastases in penile squamous cell carcinoma: a prospective pilot study. Eur J Nucl Med Mol Imaging Ouyang W, Tong X, Hou W, Zhou C, Fu H, Liu J, Wang Q, Liu Z, Yao K, Li X, Zhao M, Wang L. PMID: 42213124 [PubMed - as supplied by publisher]
	Long-Term Clinical Outcomes of Advanced Germ Cell Tumors: Experience From 105 Patients Over 20â€‰Years. Int J Urol Yamashita R, Sakura Y, Sugino T, Notsu A, Matsuo T, Hayashi Y, Ito K, Shinsaka H, Nakamura M, Matsuzaki M, Niwakawa M. PMID: 42212783 [PubMed - indexed for MEDLINE]
	Addition of Intravesical Recombinant BCG to Perioperative Chemo-Immunotherapy in Muscle-Invasive Bladder Cancer: Primary Analysis of the Single-Arm Phase 2 Trial SAKK 06/19. J Clin Oncol Cathomas R, Petrausch U, Hayoz S, Spahn M, Bubendorf L, Schäuble K, Strebel RT, Niederberger P, Stenner F, Hirschi A, Vogl U, Lorch A, Tsantoulis P, Aeppli S, Erdmann A, Maranta AF, Fankhauser C, Hötker AM, Pausch AM, Herzig P, Le Gall V, Zippelius A, Chiquet S, Rothschild SI, Rentsch CA. PMID: 42212670 [PubMed - as supplied by publisher]
	Sex-Specific Adverse Events and Cardiovascular Toxicity of Cabozantinib in Renal Cell Carcinoma: A Nine-Year Pharmacovigilance Study. Cancer Invest Bao E, Li Y, Yang Y, Wang B, Yang Q, Li S. PMID: 42212588 [PubMed - as supplied by publisher]
	Prognostic significance of pretreatment hydronephrosis in radiotherapy-based bladder-preserving strategies for muscle-invasive bladder cancer: a systematic review and meta-analysis. Arch Ital Urol Androl Nasution RFG, Warli SM, Prapiska FF. PMID: 42212459 [PubMed - as supplied by publisher]
	Updates and controversies in contemporary grading of clear cell renal cell carcinoma and papillary renal cell carcinoma. Histopathology Paner GP, Amin MB, Kwon JW, Cheng L, Moch H. PMID: 42212433 [PubMed - as supplied by publisher]
	Delayed diagnostic imaging but stable treatment initiation for kidney cancer during the COVID-19 pandemic: a Hungarian cohort study. Pathol Oncol Res Rumi L, Szántó Á, Bányai D, Szabó É, Bellyei S, Hubai D, Takáts B, Bodnár T, Girán J, Kiss I, Boronkai Á, Pozsgai É. PMID: 42211878 [PubMed - indexed for MEDLINE]
	Correction: Study on the mechanism of 18Î²-glycyrrhetinic acid inhibiting the proliferation of renal cancer cells by inducing autophagy through the miR-27a-5p/LC3 axis. Front Oncol Jia S, Zhang L, Li Y, Xu D, Yang Y, Zhou Z, Liu W, Zhao J, Yuan L, Nan Y. PMID: 42211520 [PubMed]
	Urinary DNA methylation biomarkers for bladder cancer diagnosis: a single center case-control study. Front Oncol Li C, Fang R, Wang J, Wang Y, Zhao S, Wu Q, Ying C, Rao M. PMID: 42211507 [PubMed]
	Serum micronutrient levels in men with prostate carcinoma: An observational study at a tertiary care health facility. Urologia Pareek N, Vyas N, Priyadarshi S, Agarwal N. PMID: 42210788 [PubMed - as supplied by publisher]
	CT and MRI features of renal inflammatory myofibroblastic tumor and its differential diagnosis from clear cell renal cell carcinoma and chromophobe renal cell carcinoma: a study of 13 cases from two centers. BMC Urol Du H, Wu J, Shen Q, Rong C, Wang K, Liu J, Qiu J, Wang H, Qin N. PMID: 42210207 [PubMed - as supplied by publisher]
	Robotic versus laparoscopic radical nephroureterectomy for upper tract urothelial carcinoma: comparable oncologic outcomes with reduced intravesical recurrence in pathological T3 disease. J Robot Surg Chen IA, Luo HL, Chu CH, Yu CC, Lin TP, Yang CY. PMID: 42209926 [PubMed - indexed for MEDLINE]
	Single-cell and spatial RNA sequencing in prostate cancer. Nat Rev Urol Ali A, Mikutenaite M, Weischenfeldt J, Bristow RG. PMID: 42209670 [PubMed - as supplied by publisher]
	Retroperitoneal Robot-Assisted Nephroureterectomy: Technical Description and Single Center Experience. Asian J Endosc Surg Kawashima A, Ishizuya Y, Yamamoto Y, Hayashi T, Kawamura M, Ueda N, Nakazawa S, Takezawa K, Kato T, Hatano K, Kakuta Y, Nonomura N. PMID: 42209421 [PubMed - indexed for MEDLINE]
	Cohort profile: BioCaPPE (Biomarkers of Prostate Cancer/Prevention and Environment) - a Canadian multicentre prospective study of lifestyle and candidate biomarkers in relation to prostate cancer risk. BMJ Open Moussa H, Tourigny R, Robitaille K, Bussières V, Fadel J, Ben Souilah F, Diabaté L, Hovington H, Bettan L, Lacombe L, Dujardin T, Lodde M, Toren P, Aprikian A, Saad F, Carmel M, Jeldres C, Lamarche B, Bergeron A, Fradet Y, Fradet V, Network BIOCaPPE. PMID: 42209010 [PubMed - indexed for MEDLINE]
	Molecular understanding and clinical aspects of adoptive cellular immunotherapy in prostate cancer. Crit Rev Oncol Hematol Du X, Yan Z, Su P, Liang H, Dong D, Wang K. PMID: 42208633 [PubMed - as supplied by publisher]
	Increasing and more consistent use of pre-biopsy MRI in prostate cancer diagnosis: insights from a population-based study in the Netherlands. Insights Imaging Loeff CC, Schoots IG, van Leeuwen PJ, Oprea-Lager DE, Al-Uwini S, Kiemeney LALM, van Oort IM, Aben KKH, Heesterman BL, ADMINISTRATE Study Group. PMID: 42207371 [PubMed]
	Joint effects and dynamic trajectories of metabolic insulin resistance and systemic inflammation in the risk of renal cell carcinoma: a UK Biobank cohort analysis. World J Urol Chen S, Jiang F, Wang J, Li J, Tan W, Ren J, Zhang M, Feng D. PMID: 42207184 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 178611

Seite 1 von 8931

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung